Walvax沃森生物

CN
EN

00

-0.22 (-0.6%)

Stock Code: 300142

Key Facts

3.5 billion

USD3.5 billion market capitalization

571.4 million

USD571.4 million revenue in 2023

71 million

USD71 million operating profit in 2023

58.2 million

USD58.2 million of net profit attributable to Company owners in 2023

706.5 million

USD706.5 million revenue in 2022

130.3 million

USD130.3 million operating profit in 2022
Financial Reports
2024.04.01
2023 Annual Report
Download
2023.10.31
2023 Third-Quarter Report
Download
2023.08.28
2023 Interim Report
Download
2023.04.24
2023 First-Quarter Report
Download
2023.04.03
2022 Annual Report
Download
2022.08.11
2022 Interim Report
Download
2022.03.21
2021 Annual Report
Download
2021.03.21
2020 Annual Report
Download
2020.03.21
2019 Annual Report
Download